A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2011
12/15/2011	US20110305766 Method for Controlled Release of Parathyroid Hormone from Encapsulated Poly(Lactic-Glycolic)Acid Microspheres
12/15/2011	US20110305765 Preparation and methodology of silk fibroin nanoparticles
12/15/2011	US20110305763 Lantibiotics and uses thereof
12/15/2011	US20110305760 Tissue regeneration system
12/15/2011	US20110305752 Liposome-encapsulated glutathione for oral administration
12/15/2011	US20110305751 Glutathione-based drug delivery system
12/15/2011	US20110305750 Membrane type-1 matrix metalloprotein inhibitors and uses thereof
12/15/2011	US20110305741 Composition and Method for Delivery of BMP-2 Amplifier/Co-Activator for Enhancement of Osteogenesis
12/15/2011	US20110305740 Granulated powder containing vegetable proteins and maltodextrins, process for producing same, and uses thereof
12/15/2011	US20110305732 Methods and uses for inhibiting platelet coagulation
12/15/2011	US20110305728 Drug for treating infections
12/15/2011	US20110305723 Molecular Antigen Array
12/15/2011	US20110305722 Mage-c2 antigenic peptides and uses thereof
12/15/2011	US20110305721 Compounds and methods for immunotherapy and diagnosis of tuberculosis
12/15/2011	US20110305720 Peptide adjuvants
12/15/2011	US20110305717 Cultured myeloid dendritic cells isolated from peyer's patches and uses thereof
12/15/2011	US20110305710 Novel compounds for the treatment of glaucoma or ocular hypertension
12/15/2011	US20110305707 Compositions and methods for treating cancer
12/15/2011	US20110305705 Antibodies to thymic stromal lymphopoietin receptor molecules and uses thereof
12/15/2011	US20110305691 Modified polypeptides stabilized in a desired conformation and methods for producing same
12/15/2011	US20110305689 Treatment of chronic inflammatory respiratory disorders
12/15/2011	US20110305686 Therapies for chronic renal failure using one or more integrin antagonists
12/15/2011	US20110305685 Supramolecular approach for preparation of size controllable nanoparticles
12/15/2011	US20110305682 Compositions and Methods for Treating S. Pneumonia Infection
12/15/2011	US20110305674 Pathways to Generate Hair Cells
12/15/2011	US20110305669 Process for the preparation of glycosylated interferon beta
12/15/2011	US20110305668 Methods for using interferon gamma to absorb fluid from the subretinal space
12/15/2011	US20110305667 Use of a dead-box rna helicase for inducing cytokine production
12/15/2011	US20110305666 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
12/15/2011	US20110305665 Pegylated interleukin-10
12/15/2011	US20110305664 Novel vaccines against multiple subtypes of influenza virus
12/15/2011	US20110305663 Serum albumin binding molecules
12/15/2011	US20110305662 Methods of treating immunodeficiency virus infection
12/15/2011	US20110305661 Carbazole Compounds and Therapeutic Uses of the Compounds
12/15/2011	US20110305647 Use of a polysaccharide which is excreted by the vibrio diabolicus species for the regeneration and protection of the periodontium
12/15/2011	US20110305641 Compositions And Methods For Treatment Of Angiogenesis-Associated Ocular Disorders
12/15/2011	US20110305639 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
12/15/2011	US20110305634 Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
12/15/2011	US20110305633 Methods for Treatment, the Prognostic Assessment and the Detection of Breast Cancer
12/15/2011	US20110305632 Process for the preparation of asymmetrical bis(thiosemicarbazones)
12/15/2011	US20110305631 Camptothecin Conjugates of Anti-CD22 Antibodies for Treatment of B Cell Diseases
12/15/2011	DE10392821B4 Synteseverfahren für Alanylglutamin Synteseverfahren for alanylglutamine
12/15/2011	CA2807271A1 Nanoparticle film delivery systems
12/15/2011	CA2802176A1 Methods of mitigating effects of radiation and reducing the risk of systemic infection
12/15/2011	CA2802031A1 Peptide-carrying nanoparticles
12/15/2011	CA2801971A1 Novel auristatin derivatives and their use
12/15/2011	CA2800911A1 Immunogenic vaccine
12/15/2011	CA2800408A1 A heterogeneous inseminate system
12/15/2011	CA2743527A1 Use of a combination of an inhibitor of the if current of the sinus node and an inhibitor of the angiotensin converting enzyme for the treatment of heart failure
12/15/2011	CA2739107A1 Methods and uses for inhibiting platelet coagulation
12/14/2011	EP2395112A1 Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence
12/14/2011	EP2395099A2 Amino acid substituted molecules
12/14/2011	EP2395076A1 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
12/14/2011	EP2395015A1 Novel peptides for wound healing
12/14/2011	EP2395013A2 Proteins comprising conserved regions of Neisseria meningitidis surface antigen NhhA
12/14/2011	EP2394656A2 Propylene Glycol-containing peptide formulations which are optimal for production and for use in injection devices
12/14/2011	EP2394655A2 Epitope sequences
12/14/2011	EP2393832A1 Truncated cystine-knot proteins
12/14/2011	EP2393830A1 Grass peptides for vaccine
12/14/2011	EP2393829A1 Actagardine derivatives
12/14/2011	EP2393508A1 Glp-1 analogues pharmaceutical compositions
12/14/2011	EP2393507A2 Trimerich hiv fusion inhibitors for treating or preventing hiv infection
12/14/2011	EP2393506A1 Methods and compositions for treating neuropathies
12/14/2011	EP2393505A1 Use of specific peptides in the preparation of a medicament for the treatment of monoclonal gammopathy of undetermined significance (mgus) or of smoldering multiple myeloma (smm)
12/14/2011	EP2393504A2 Pharmaceutical composition containing l-ribozyme for treating adverse reactions by administering spiegelmers
12/14/2011	EP2393501A1 Method and means for producing tissues and tissues obtained
12/14/2011	EP2393497A1 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
12/14/2011	EP2393494A1 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
12/14/2011	EP2240198B1 Composition for absorption through mucous tissue
12/14/2011	EP2158213B1 Vm23 and vm24, two scorpion peptides that block human t-lymphocyte potassium channels (sub-type kv1.3) with high selectivity
12/14/2011	EP1908449B1 Sterilizer selective to cariogenic bacterium, and method for sterilization of cariogenic bacterium
12/14/2011	EP1735344B1 Vaccine composition comprising a class ii mhc ligand coupled with an antigen, method for the preparation and the use thereof
12/14/2011	EP1684792B1 Pharmaceutical formulations for the sustained release of interleukins and therapeutic applications thereof
12/14/2011	EP1531851B1 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
12/14/2011	EP1503798B1 Stabilised solid compositions of modified factor vii
12/14/2011	EP1399108B1 Preparation of a therapeutic composition
12/14/2011	EP1085090B1 IgA NEPHROPATHY-ASSOCIATED DNA
12/14/2011	EP1005488B2 Receptor that binds trail
12/14/2011	CN1720060B 人乳头瘤病毒多肽和免疫原性组合物 HPV polypeptides and immunogenic compositions
12/14/2011	CN1582337B 丙型肝炎病毒疫苗 Hepatitis C virus vaccine
12/14/2011	CN102282169A 表达破骨细胞相关受体的细胞活性和分化的调节 Expression regulation of osteoclast cell activity associated receptors and differentiation
12/14/2011	CN102282168A 人血清白蛋白接头以及其结合物 Human serum albumin and combinations thereof linker
12/14/2011	CN102282166A 胰高血糖素类似物 Glucagon analogs
12/14/2011	CN102282165A Gdnf剪接变体及其用途 Gdnf splice variants and their uses
12/14/2011	CN102282162A 用于增强dna修复的物质和组合物及使用方法 Dna repair for enhancing substances and compositions and methods of use
12/14/2011	CN102282159A 肽衍生物及其以结合物形式作为分子载体的应用 Derivatives peptides and Its Application in the form of a conjugate of a carrier molecule
12/14/2011	CN102282158A 氮杂酮衍生物 Aza derivatives
12/14/2011	CN102281890A Sparc结合肽及其应用 Sparc binding peptide and its application
12/14/2011	CN102281868A 成骨蛋白复合物的新型施用形式 The new administration in the form of a bone protein complexes
12/14/2011	CN102281865A 高浓缩药物颗粒、制剂、混悬剂及其应用 Highly concentrated drug particles, preparation, and application of suspensions
12/14/2011	CN102277364A 融合蛋白LhFVII-LDP和强化融合蛋白LhFVII-LDP-AE及其应用 The fusion protein LhFVII-LDP and strengthen the fusion protein LhFVII-LDP-AE and its application
12/14/2011	CN102276731A 抑制可卡因诱发的高运动活性的多肽及其应用 Suppression of cocaine-induced locomotor activity in polypeptides and their high application
12/14/2011	CN102276727A IL-17RC-hFc融合蛋白及其应用 IL-17RC-hFc fusion protein and its application
12/14/2011	CN102276726A 肝细胞生长因子受体活性基团的融合蛋白 Hepatocyte growth factor receptor fusion protein reactive groups
12/14/2011	CN102276698A 一种mc4-r环肽类激动剂及其用途 One kind mc4-r cyclic peptide agonists and their uses
12/14/2011	CN102276695A 具有降血压功能的多肽及其用途 Have lower blood pressure function of polypeptides and uses
12/14/2011	CN102276694A 猪血来源的降血压多肽及其用途 Pig-derived peptides and their use hypotensive
12/14/2011	CN102276693A 猪血降血压功能多肽及其用途 Pig blood pressure function of the polypeptide and its use
12/14/2011	CN102276692A 功能多肽及其用途 Functional peptides and their use
12/14/2011	CN102276690A 降血压功能性多肽及其用途 Lowering blood pressure and its use functional polypeptide

1 ... 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 ... 3163